Sign in

Trial site

Istituto Nazionale Tumori Regina Elena IRCCS

Roma, 00144, ItalyNot linked to an institution yet
  • 1running trial
  • 1closed trial

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions
Phase
  • Phase 21 trial
  • Phase 31 trial
Status
  • Active, not recruiting1 trial
  • Terminated1 trial
Lead sponsor
  • NS Pharma, Inc.1 trial
  • Pierre Fabre Medicament1 trial

Running trials

Closed trials

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Istituto Nazionale Tumori Regina Elena IRCCS: trial site – Frontlight Research